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GABA transporter subtype 1 (GAT1) molecules were counted
near GABAergic synapses, to a resolution of 0.5 m. Fusions
between GAT1 and green fluorescent protein (GFP) were tested
in heterologous expression systems, and a construct was se-
lected that shows function, expression level, and trafficking
similar to that of wild-type (WT) GAT1. A strain of knock-in mice
was constructed that expresses this mGAT1–GFP fusion in
place of the WT GAT1 gene. The pattern of fluorescence in
brain slices agreed with previous immunocytochemical obser-
vations. [3H]GABA uptake, synaptic electrophysiology, and
subcellular localization of the mGAT1–GFP construct were also
compared with WT mice. Quantitative fluorescence microscopy
was used to measure the density of mGAT1–GFP at presynap-
tic structures in CNS preparations from the knock-in mice.
Fluorescence measurements were calibrated with transparent
beads and gels that have known GFP densities. Surface bioti-
nylation defined the fraction of transporters on the surface
versus those in the nearby cytoplasm. The data show that the
presynaptic boutons of GABAergic interneurons in cerebellum
and hippocampus have a membrane density of 800–1300 GAT1
molecules per square micrometer, and the axons that connect
boutons have a linear density of 640 GAT1 molecules per
micrometer. A cerebellar basket cell bouton, a pinceau sur-
rounding a Purkinje cell axon, and a cortical chandelier cell
cartridge carry 9000, 7.8 million, and 430,000 GAT1 molecules,
respectively; 61–63% of these molecules are on the surface
membrane. In cultures from hippocampus, the set of fluores-
cent cells equals the set of GABAergic interneurons. Knock-in
mice carrying GFP fusions of membrane proteins provide quan-
titative data required for understanding the details of synaptic
transmission in living neurons.
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When uptake by the GABA transporter GAT1 is inhibited,
evoked IPSCs are prolonged at some synapses, presumably be-
cause transmitter molecules remain near receptors and reactivate
them (Dingledine and Korn, 1985; Roepstorff and Lambert, 1992,
1994; Thompson and Gahwiler, 1992; Draguhn and Heinemann,
1996; Engel et al., 1998). However, miniature GABAergic IPSCs
(mIPSCs) are not prolonged by GAT1 blockers. GAT1 also limits
“spillover” to receptors outside the immediate synaptic cleft dur-
ing repetitive presynaptic stimulation (Isaacson et al., 1993). In
another spillover phenomenon, GAT1 inhibition produces tonic
GABAA currents at high-affinity extrasynaptic receptors in hip-
pocampus (Frahm et al., 2001; Overstreet and Westbrook, 2001;
Tang et al., 2001) and cerebellum (Brickley et al., 1996).
Understanding the role of GABA uptake in these and other
aspects of GABAergic transmission requires knowing key param-
eters and mechanisms. Quantitative studies of local GABAA
receptor number (Nusser et al., 1997, 1998a,b) and of GABA
receptor kinetics (Jones and Westbrook, 1995) are available.
Although substantial mechanistic knowledge is available about
the molecular physiology of the most widespread GABA trans-
porter in the CNS, GAT1 (Guastella et al., 1990; Mager et al.,
1993; Hilgemann and Lu, 1999), little is known about the density
of this molecule at actual synapses. Detailed simulations of
GABAergic transmission have assumed densities on the order of
500/m2 (Jones and Westbrook, 1995; Jones et al., 1998, 1999).
This study was conducted to quantify the number and density
of GAT1 near synapses. We constructed a strain of knock-in mice
that express a GAT1–green fluorescent protein (GFP) fusion in
place of the wild-type (WT) GAT1 gene. We calibrated the
fluorescence measurements by exploiting previously described
transparent beads that themselves have known GFP densities
(Chiu et al., 2001) and by extending the calibrations with gels
traceable to the beads. The resulting measurements show that
GAT1 density is rather high at GABAergic presynaptic terminals.
A complication is introduced by the fact that GAT1, like many
neurotransmitter transporters, is dynamically regulated by sur-
face/cytoplasmic partitioning (Corey et al., 1994; Beckman and
Quick, 1998, 1999; Whitworth and Quick, 2001a,b); therefore, we
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have used surface biotinylation to define the fraction of transport-
ers on the surface versus those in the nearby cytoplasm.
In addition to timely removal of GABA released spontaneously
or by presynaptic impulses, other possible functions of GABA
transporters include replenishing the supply of GABA in an
inhibitory neuron and releasing GABA in a voltage-dependent
but Ca2-independent mechanism (Lester et al., 1996). To assess
these roles, it is helpful to know which cells express GABA
transporters. GABAergic interneurons are a heterogeneous pop-
ulation (Freund and Buzsaki, 1996), and there are reports that
only some inhibitory interneurons express GAT1 (Engel et al.,
1998) and that some excitatory neurons also express GAT1 (Yan
et al., 1997). Furthermore, the ability to identify GABAergic
neurons in culture would be a methodological contribution. We
therefore performed synaptic electrophysiology on neurons in
hippocampal cultures from knock-in mice, and we found that all
GABAergic cells, and only GABAergic cells, fluoresce.
MATERIALS AND METHODS
mGAT1 and GFP fusion constructs. GFP37 was fused to the N terminus
of mGAT1 (Liu et al., 1992) (GenBank M92378) by PCR cloning using
SalI and EcoRI sites on the pGFP37 plasmid (Grabner et al., 1998; Chiu
et al., 2001). This construct carries an eight-residue spacer between
GFP37 and mGAT1. To fuse GFP to the C terminus of mGAT1, the
mGAT1 open reading frame was subcloned into the HindIII and EcoRI
sites of pcDNA3.1(), and the GFP coding sequence was subcloned into
the NotI and XbaI sites. A 12-residue spacer between mGAT1 and GFP
was introduced by the multiple cloning site of the vector:
CGA ATT CTG CAG ATA TCC AGC ACA GTG GCG GCC GCC
R I L Q I S S T V A A A
The WT mGAT1 control and GFP control were subcloned between
the HindIII and EcoRI and between the NotI and XbaI sites in
pcDNA3.1(), respectively.
Human embryonic kidney (HEK) 293T cells were plated on 35 mm
plates to 50–70% confluence, transfected with the fusion constructs
(Effectene, Qiagen), and incubated for an additional 60 hr. For GABA
uptake assays, cells were washed twice with Krebs’–Ringer’s (KRH)
buffer (Ramamoorthy et al., 1998), incubated in 2.5 M [ 3H]GABA (89
Ci/mmol; Amersham), in 2.2 [ 3H]GABA Ci/ml in KRH at room
temperature for variable periods, or at variable [GABA] (2.2–8.8 Ci/
ml) for 10 min, washed rapidly four times with KRH buffer containing 2.5
M GABA, and solubilized in 1% SDS. [ 3H]GABA was assayed using
liquid scintillation.
A lentivirus expression construct was constructed using the three-
plasmid expression system as described (Naldini et al., 1996; Dull et al.,
1998; Nadeau et al., 2000). The pHR vector was linearized with XhoI
and MluI. The mGAT1–GFP fusion construct in pcDNA 3.1() was
ligated into pHR by PCR using primers containing the appropriate
restriction sites (XhoI and MluI). Aliquots of the lentivirus suspension
were stored at 80°C, thawed once, and applied (15–20 l) to Madin-
Darby canine kidney (MDCK) cells.
Knock-in mouse targeting construct. The mGAT1 cDNA fragment di-
gested with AccI and StuI (position 715–1785 in the coding sequence) was
used to synthesize a random primed [ 32P]dCTP probe using the pro-
tocol from the NEBlot kit (BioLabs). A 129 SVEV Tac FBR mouse
spleen genomic library (Lambda FIX II genomic library; Stratagene) was
screened. We isolated 26 genomic clones and identified one clone (#6)
that carried intron 14 and exon 15 and had 4.0 kb of flanking genomic
sequence on both arms.
Genomic clone #6 was amplified by subcloning into the NotI site in
pBluescript. The amplified mGAT1 genomic clone #6 was subcloned
into the HindIII site of pBluescriptSK() and subsequently subcloned
into pKO vector (Lexicon Genetics), which carries the diphtheria toxin
gene as a positive selection marker, using the SalI and EcoRI sites from
pBluescript. The genomic DNA in the pKO vector was modified by
inserting the 12-residue spacer plus GFP coding sequence just 5 to the
stop codon of mGAT1 (Exon #15; position 17617) by PCR using three
pairs of primers. This construct was confirmed by sequencing. To elim-
inate restriction sites in the 12-residue spacer between mGAT1 and GFP,
the spacer sequence was modified with silent mutations via the PCR
primers:
CGC ATT CTC CAA ATC TCA AGC ACC GTA GCC GCA GCC
R I L Q I S S T V A A A
The floxed Neo cassette was inserted between position 17303 and
17311 (intron #14), where AscI sites were created by PCR. The floxed
Neo cassette was modified by creating AscI sites on both ends by linkers.
An additional 1.6 kb flanking arm at the 3 end of this construct was
created by replacing the ApaI /EcoRI sites in the pKO vector with the
corresponding mGAT1 genomic DNA sites. The final construct has 3.8
kb on the 5 arm, –Neo-320 bp-GFP-, and 4.2 kb on the 3 arm for
homologous recombination (Fig. 1 A). The 320 bp sequence includes the
34 residues of the coding portion of exon 15.
Homologous recombination, blastocyst injection, and mouse breeding. J7
embryonic stem (ES) cells from 129S3SvImJ mice were electroporated
with the linearized construct and screened with Geneticin (G418; 180
g/ml). The ES cell clones that survived this screening were further
screened by PCR (Long template PCR kit; Roche) using a primer set
that anneals to position 13017–43 and the neomycin resistance cassette
(Neo): mGAT1 13017–43: 5-GAC TGG TGG GAG AGG CAG ACT
TTG AAC-3; Neo-cassette 3: 5-CCA AGT TCT AAT TCC ATC
AGA AGC TCC-3.
The recombined mGAT1 gene showed a 4.5-kb PCR product (Fig.
1 B). Positive clones were confirmed by PCR using additional sets of
primers. Two clones were injected into the C57 blastocyst. Chimeras that
displayed 60% agouti coloring were mated with C57 females to gener-
ate heterozygous mice. These mice carry the Neo-cassette in intron 14
and were named intron 14-Neo-mGAT1. The loxP-flanked Neo-cassette
was deleted by mating with DBA mice carrying cre recombinase. This
deletion leaves the 34 bp of one loxP site plus restriction sites (SwaI-
AscI) in the intron, and this Neo-deleted strain was named mGAT1-GFP
(Fig. 1C).
To genotype the mice (Fig. 1 D), three PCR primers were used for
screening the GFP insertion: mGAT1 17399–430: 5-GAC ATT TGG
CTT ACT AGT GAG GAA ACA AGA GC-3; mGAT1 17830–799:
5-GCT AAG GGG CCT CTA CGG AAG CCT CCA GAG GC-3; and
GFP37 995–64: 5-CCA TCT AAT TCA ACA AGA ATT GGG ACA
ACT CC-3.
To confirm deletion of the Neo-cassette, the primers were as follows:
mGAT1 16922–54: 5-CCA TGA GGT TGG CTG GAG GGA GAA
TAA TGT AGC-3; mGAT1 17521–54: 5-GCA CAA TAT CTT CAC
TGG GCT GAA TCA TGA CCT G-3; and Neo-cassette 3: 5-CCA
AGT TCT AAT TCC ATC AGA AGC TCC-3.
GFP calibrations. Brain slices, MDCK cells, GFP-beads, and GFP in
polyacrylamide gels were imaged using a Leica SP1 confocal microscope
system. The confocal system was warmed up for 2 hr, so that the laser
photopower fluctuated less than5%, monitored by a photopower meter
(ThorLabs Inc.; model S20MM) and by the transmitted light detector in
the microscope. During the 4 months of the quantitative imaging
experiments, we monitored the stability of the photomultiplier tube
(PMT) periodically by imaging the standardized GFP-beads at a stan-
dard photopower. Signals varied by 5%, indicating that the PMT is
stable.
Images were taken with a 100 plan apochromatic objective, numer-
ical aperture (NA) 	 1.4 (Leica, #506038) using 2 zoom. The pinhole
was set at 152 m, as recommended by the manufacturer. The scan speed
was 200 lines per second (slow mode), and the image size was 1024 
10 24 pixels. Each image was scanned with four repeats. The laser power
was adjusted using the microscope’s acousto-optical tunable filter, so that
the fluorescence of a sample fell within the linear range of the detection
system.
Bleaching is described by the relation, f(t) 	 f0e
kIt, where f0 and f(t)
are the fluorescence at times zero and t(sec), respectively, k is the cross
section for bleaching, measured previously as 4.7  103 (centimeters
squared per Joule) (Chiu et al., 2001), and I is the laser intensity (Watts
per centimeters squared). For instance, 0.57 W laser power (a typical
value) applied to a 50-m-square region implies that the bleaching
amounts to 8.7% at the conclusion of a 38-image z-stack series. In our
experiments, bleaching actually occurred somewhat more slowly than
this relation, probably because of scattering. Nonetheless, we used con-
ditions characterized by kIt  0.12, so that the average bleaching for a
structure within the imaged region was 6%. No formal bleaching
corrections were applied.
GFP fluorescence was calibrated using two, well understood His6–
GFP preparations. Our primary tool was a series of transparent Ni-NTA
beads with known surface densities of His6–GFP (Chiu et al., 2001).
GFP-beads prepared for this study from a stock 18 months old showed
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unchanged fluorescent intensity on the previously used imaging systems,
indicating the stability of the His6–GFP solutions. For the present study,
the beads were used to calibrate the Leica confocal microscope system.
Using GFP-beads at densities at 300, 600, and 1500 GFP per square
micrometer, we measured sensitivities of 0.10379 and 0.06944 (counts per
pixel per GFP per square micrometer) at 1.15 and 0.77 W, respectively
(Fig. 2 A).
For GFP in polyacrylamide gels (Fig. 2 B), the His6–GFP stock solu-
tion was diluted with 50 mM Tris-Cl, pH 8.0, 300 NaCl, 1.5 mg/ml BSA
to various concentrations (a final volume of 50 l) and then mixed with
an equal volume of acrylamide solution (38%, 19:1) to generate a
homogeneous polyacrylamide gel. The final concentrations of GFP in the
gel were 6900, 5500, 4120, 2750, and 1375 GFP per cubic micrometer.
The gels were sectioned at 60 m slices using a vibratome and mounted
for imaging. The sectioning and imaging were done within 30 min to
prevent GFP diffusion. The sensitivities were proportional to pho-
topower and equaled 0.02343, 0.01683, and 0.00718 (counts per pixel per
GFP per cubic micrometer) at photopowers of 1.11, 0.75 and 0.31 W,
respectively (Fig. 2 B). When these sensitivities are compared with those
obtained with GFP-beads, it may be calculated that the microscope
images fluoresce from an effective z-axis thickness of 250 nm, probably
because the microscope is gathering fluorescence from a z-axis range
somewhat 250 nm, but with an efficiency somewhat less than that for
the bead surface.
His6–GFP is stable in polyacrylamide (without SDS). We monitored
His6–GFP fluorescent intensity before and after the gel was polymerized
using a fluorometer and found no changes (data not shown). This agrees
with a previously published paper that characterized GFP in polyacryl-
amide gels (Dickson et al., 1997). Exposing the GFP-beads to 4%
paraformaldehyde, pH 8.0, did not interfere with GFP fluorescent inten-
sity (data not shown) (Chalfie et al., 1994; Brock et al., 1999), indicating
that no corrections are necessary for fixation with 4% paraformaldehyde
in mouse brain.
Sample preparation. Mice were anesthetized with halothane (2-bromo-
2-chloro-1,1,1-trifluorothane) and perfused with 4% paraformaldehyde
in PBS, pH adjusted to 7.6 with Na2HPO4. Brains were dissected and
kept in 4% paraformaldehyde for 1 hr in 4°C and then incubated in 30%
sucrose in PBS for20 hr. The brains were embedded in O.C.T. medium
(Tissue-Tek) for either horizontal or sagittal sections and sliced by
cryostat at 35 m. Brain slices were stored in 11 mM NaH2PO4, 20 mM
Na2HPO4, 30% ethylene glycol, and 30% glycerol, pH 7.5, at 20°C.
Before imaging, slices were rinsed with PBS and mounted with Vectash-
ield (refractive index 1.4577).
mGAT1–GFP intensity measurement using CCD camera. Surveys of
mGAT1–GFP expression measurement in sagittal brain slices (see Fig.
4 B) were performed with an epifluorescence microscope (Nikon Eclipse
300) equipped with a CCD camera using a 2 objective. We chose 14
regions that represent the range of GFP intensity in the brain and
gathered five images of each region using a 100 objective (NA 1.4). The
averaged fluorescent intensity from each region was normalized to that of
the Purkinje cell pinceaux.
Confocal imaging and quantification. For imaging Neo-deleted mice,
the laser power was set between 0.75 and 1.1 W. We estimated that the
autofluorescence from a WT brain slice is equivalent to 10–20 GFP per
square micrometer (Chiu et al., 2001), which is 1–2% of the density of
mGAT1–GFP expression. No correction was made for this background
fluorescence.
Using ImageJ, we selected boutons, axons, pinceaux, and cartridges for
quantification from stacks of images (81 nm per step). The GFP volume
density of a structure was determined by dividing (calculated average
fluorescent intensity)/(slope of the standard curve, intensity per pixel per
GFP per cubic micrometer) at similar photopower (Fig. 2 B). The total
GFP molecules in a structure were calculated by multiplying the volume
(total number of voxels) times the measured average density.
The GAT1–GFP surface density was calculated by dividing the surface
area (sum of pixels) by the total number of GFP molecules. Heterozy-
gotes and homozygotes gave equally precise data, but counts from the
heterozygotes were half that from homozygotes and were multiplied by 2
for density measurements.
Fluorescence intensity decreases beneath the tissue surface along the
z-axis with a space constant of 35 m (Fig. 2C,D), primarily because of
refractive index mismatches and other causes of light-scattering effect
that have been described and characterized previously (Hell et al., 1993;
Pawley, 1995). We confined our measurements to the superficial 3–4 m
of brain slices, so that fluorescence decremented by 10%.
Figure 1. Generation and screening of knock-in strains. A, Modification
of mGAT1 genomic DNA to generate a targeting plasmid that contains an
mGAT1–GFP fusion sequence in an exon and a floxed neomycin selec-
tion cassette in an intron. See Materials and Methods for details. B, PCR
screening to identify ES cells carrying the mutant gene. A 4.5 kb PCR
product is expected. Lanes 1, 3, and 4 represent positive ES cell clones;
lane 2 is a negative clone. Lanes 5 and 6 show negative controls with no
PCR products from genomic DNA extracted from WT ES cells and from
the final pKO plasmid construct shown in A. Lane M shows molecular
length standards. C, Generation of the Neo-deleted mGAT1–GFP
knock-in mouse. The intron 14-Neo-mGAT1 heterozygotes were mated
with DBA mice carrying cre recombinase to eliminate the neomycin
selection cassette. D, Exemplar PCR genotyping results. Lanes 1–3 show
PCR products for mice that are homozygous for the presence of the GFP
fusion, heterozygous, and WT, respectively. Lanes 4–6 represent the
screening for mice that are homozygous for the presence of the Neo
cassette, heterozygous, and WT, respectively.
Chiu et al. • GABA Transporter–GFP Counted in Knock-In Mice J. Neurosci., December 1, 2002, 22(23):10251–10266 10253
Biotinylation. Biotinylation experiments were performed essentially as
described (Qian et al., 1997; Davis et al., 1998). Cerebellar slices (200
m) from postnatal day (P) 30 mice were rinsed twice with 37°C PBS/
Ca/Mg containing (in mM): 138 NaCl, 2.7 KCl, 1.5 KH2PO4, 9.6
Na2HPO4, 1 MgCl2, 0.1 CaCl2, pH 7.4. The tissue was next incubated
with 2 ml of a solution containing 1 mg/ml sulfo-NHS biotin (Pierce) in
PBS/Ca/Mg for 1 hr at 4°C with gentle shaking. The biotinylation
solution was removed by three washes in PBS/Ca/Mg plus 100 mM
glycine and quenched in this solution by incubating the cells at 4°C for 45
min with gentle shaking. The tissue was then homogenized in 1 ml RIPA
buffer containing 100 mM Tris-Cl, pH 7.4, 150 mM NaCl, 1 mM EDTA,
1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 g/ml leupep-
tin, 1 g/ml aprotinin, and 250 M PMSF. The lysates were centrifuged
at 20,000  g at 4°C for 60 min. The supernatant fractions (300 l) were
incubated with an equal volume of Immunopure immobilized mono-
meric avidin beads (Pierce) for 60 min. The beads were washed three
times with RIPA buffer, and adsorbed proteins were eluted with SDS
sample buffer (62.5 mM Tris-Cl, pH 6.8, 2% SDS, 100 mM
-mercaptoethanol) at room temperature for 30 min. Analysis was per-
formed on aliquots (1) taken before incubation with beads (total cell
lysate), (2) of the supernatant fraction after adsorption and centrifuga-
tion (the nonbiotinylated, “intracellular” fraction), and (3) of the bead
eluate (the biotinylated, “surface” fraction). Samples were then run on a
10% acrylamide gel and transferred to nitrocellulose membrane. West-
ern blotting was performed using an anti-GAT1 antibody (Corey et al.,
1994) at 1:200 and an anti-GFP antibody (Chemicon) at 1:500.
Dissociated culture. Neuronal cultures were prepared as described (Li
et al., 1998). Briefly, hippocampi from embryonic day (E) 16 embryo were
digested with 0.25% trypsin and then triturated. Cells plated in
polyethyleneimine-coated glass-bottom dishes (400 cells per square mi-
crometer) were maintained in Neurobasal medium supplemented with
B27, 500 M Glutamax, and 5% horse serum (Invitrogen). Dual whole-
cell recording was used after 8–14 d in culture. A presynaptic cell was
current clamped at zero current except for 1 msec 0.5–1 nA outward
stimulus pulses. Postsynaptic currents were recorded at membrane po-
tentials ranging from 100 to 0 mV. The criterion for a monosynaptic
response was a latency3 msec. The presence or absence of fluorescence
was established visually and confirmed by video images with an exposure
time of 0.5 sec. Composition of solutions was as follows (in mM): bath:
140 NaCl, 5.4 KCl, 2 CaCl2, 1 MgCl2, 5 HEPES, 5 glucose, pH 7.4;
pipette: 150 K gluconate, 5 NaCl, 0.1 CaCl2, 1 MgCl2, 5 EGTA, 5
HEPES, pH 7.2. Resting membrane potential ranged from 65 to 50
mV. Input resistances were 0.4–1 G
.
Synaptosomal preparation and GABA uptake assay. Mice were anesthe-
tized with halothane, and brains were dissected and collected on ice. The
cerebellum (50 mg) was homogenized in 20 (w/v) medium I (0.32 M
sucrose, 0.1 mM EDTA, and 5 mM HEPES, pH 7.5) using a Teflon-glass
homogenizer with 16 strokes. Synaptosomes were prepared (Nagy and
Delgado-Escueta, 1984). The particulate fraction (P2) from the final
centrifugation was suspended with 1 ml of medium I (1 mg/ml).
Twenty microliters of the suspension from the P2 particulate fraction
were mixed with 280 l of uptake buffer containing (in mM): 128 NaCl,
2.4 KCl, 3.2 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 10 glucose, 25 HEPES, pH
7.5 (Lu et al., 1998) and incubated at 37°C for 10 min. Subsequently, 100
l of [ 3H]GABA at various concentrations was added and incubated for
the indicated periods (final radioactive concentrations, 2.2–8.8 Ci/ml).
Samples were placed on ice, washed with uptake buffer containing the
same concentration of nonradioactive GABA at 10,000 g, and counted.
The GAT1 activity, defined by sensitivity to the specific GAT1 inhibitor
NO-711 (30 M final), accounted for 75–85% of WT activity.
Translocation treatments. For synaptosomal GABA uptake assays, syn-
aptosomes were pretreated with 50 M orthovanadate, 100 nM bisindolyl-
maleimide II, and 0.45 M sucrose at 37°C for 15 min and then transferred
to synaptosomal GABA uptake buffer at 4°C. The GABA uptake assay
lasted for 1 h at 4°C.
To prepare living brain slices for quantitative imaging and Western
blot, mice were anesthetized, and brains were dissected free. Brains were
then kept in ice-cold artificial CSF (ACSF) containing (in mM): 126
NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, 10
D-glucose, and 3 kynurenic acid, pH 7.3, bubbled with 95% O2 and 5%
CO2. The brain was then sliced by vibratome at 120 m thickness. The
slices were incubated at 37°C in 50 M orthovanadate, 100 nM bisindolyl-
maleimide II, and 0.45 M sucrose for 15 min. Slices were transferred to
ice-cold ACSF. Some slices were subjected to biotinylation and quanti-
tative Western blot as described in the previous section. Other slices were
fixed in ice-cold ACSF containing 4% paraformaldehyde for 20 min.
After a rinse with ACSF, slices were mounted and subjected to imaging.
Brain slice electrophysiology. Mice (P15–P25) were anesthetized with
halothane before decapitation, according to University of California Los
Angeles regulations. The brain was placed in ice-cold ACSF bubbled
with 95% O2 and 5% CO2. Coronal slices (350 m thick) were cut with
a Leica VT1000S Vibratome and stored in bubbled ACSF for 1 hr.
Whole-cell recordings were made at 32–33°C from CA1 pyramidal
cells (Zeiss Axioscope infrared-differential contrast videomicroscopy)
with an Axopatch 200B amplifier. Electrodes were pulled (Narishige
PP-83; Narishige, Tokyo, Japan) from borosilicate glass and filled with
solution containing (in mM): 140 CsCl, 2 MgCl2, 10 HEPES, pH 7.2 with
CsOH. Voltage-clamp recordings were made at a Vhold of 70 mV. The
Figure 2. GFP characterization in beads,
gels, and tissue samples. A, B, Calibration
lines generated for His6–GFP beads (A) and
His6–GFP in polyacrylamide gels (B) using
the Leica confocal system. The measured
slopes for His6–GFP beads are 0.10379 and
0.06944 (counts per pixel per GFP per square
micrometer) at 1.15 and 0.77 W, respec-
tively. The measured slopes for His6–GFP in
polyacrylamide gels were 0.02343, 0.01683,
and 0.00718 (intensity per pixel per GFP per
cubic micrometer) illuminated with 1.11,
0.75, and 0.31 W, respectively. C, x–z pro-
jection of a slice from the cerebellar ML
region. Scale bar, 10 m. D, The profile of
the decreased fluorescent intensity along the
z-axis, averaged along the x-axis from C.
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resistance of the electrodes was 3–6 M
, and series resistance was
compensated by 70–85% (lag 7–8 sec). Recordings were low-pass
filtered at 3 kHz and digitized at 20 kHz. Synaptic events were detected
with amplitude-based (threshold 6–7 pA) and kinetics-based criteria
using custom-written software (LabView, National Instruments). Tonic
GABAA receptor-mediated currents were examined by applying the
selective GABAA antagonist SR-95531 to the slice chamber in a final
concentration of 100–150 M (30–35 l of a 6–8 mM SR-95531 solution;
chamber volume 1.8–2.0 ml) (Brickley et al., 1996). The holding current
was measured in 5 msec epochs at 100 msec intervals, and epochs were
rejected if contaminating IPSCs were present. The mean holding current
was calculated in three 5-sec-long periods (a, b, and c): a, 20 sec before
SR-95531 application; b, just before SR-95531 application; c, 20 sec after
the application. The tonic GABAA current was calculated as c  b.
RESULTS
cDNA constructs and functional assays
We fused the cDNA for a GFP mutant (GFP37, named for its
stability at 37°C) (Grabner et al., 1998) to either the N or C
terminal of the cDNA for mouse GAT1 (mGAT1) (Fig. 3A) and
began by testing HEK 293T cells transfected with these constructs
(Fig. 3B–D). A control construct, expressing GFP alone, dis-
played uniform diffuse fluorescence throughout the cell including
the nucleus (Fig. 3C), and the GABA uptake activity was indis-
tinguishable from nontransfected cells (Fig. 3E,F).
The C-terminal fusion mGAT1–GFP, which includes a 12-
residue spacer between mGAT1 and the GFP, showed clear
plasma membrane localization (Fig. 3D) as well as cytoplasmic
localization, which is typically found with overexpressed mem-
brane proteins. GABA uptake activity was similar to that of WT
mGAT1 (Fig. 3E,F). In Scatchard analysis, the EC50 values for
mGAT1 and mGAT1–GFP were 10.9 and 9.3 M, respectively,
and the Vmax values were 3.6 and 3.9 nmol/mg protein per 10 min,
respectively.
The N-terminal fusion protein, however, was localized primarily
Figure 3. Testing and selecting the mGAT1–GFP fusion. A, The four constructs, mGAT1–GFP, mGAT1, and GFP in pcDNA3.1(), and GFP–
mGAT1 in pGFP37 were made to test the function of mGAT1–GFP fusions. The spacer sequences (8 residues for GFP–mGAT1, 12 residues for
mGAT1–GFP) are shown in red. The C-terminal AYI sequence is shown in blue. B, The GFP–mGAT1 fusion is expressed mostly in the cytoplasm but
not the nucleus of HEK cells and shows only slight increases in GABA uptake (data not shown). C, GFP expresses in cytoplasm and in the nucleus. D,
The mGAT1–GFP fusion protein expresses on the membrane of HEK cells as well as in the cytoplasm, a typical situation for overexpressed proteins.
E, F, Kinetics of GABA uptake by these fusion proteins expressed in HEK cells, tested at 2.5 M GABA for time dependence (E) and in a 10 min assay
for concentration dependence (F). mGAT1–GFP GABA uptake activity (E, green line) was indistinguishable from that of WT mGAT1 (F, black line).
On the other hand, HEK cells expressing GFP (Œ) have GABA uptake activity indistinguishable from noninfected cells. The GFP–mGAT1 fusion
showed only slight increases in GABA uptake compared with untransfected cells (data not shown). G, H, Fluorescence on the apical membrane of
MDCK cells transfected with a recombinant mGAT1–GFP lentivirus. The face-on view of an image stack (G) and the side view of the same stack (H )
are illustrated. I, mGAT1 expressed in a cultured E18 hippocampal cell, infected after 12 d in culture with the recombinant lentivirus and imaged 5 d
later. All labeled processes derive from one cell. Scale bars: B–D, 25 m; G, H, 20 m; I, 50 m.
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or exclusively in the cytoplasm rather than in the plasma mem-
brane. The transfected cells displayed GABA uptake only slightly
higher than untransfected cells and 10-fold less than WT mGAT1
or mGAT1–GFP (data not shown). The lack of nuclear expression
suggests that GFP did indeed fuse with mGAT1, forming a protein
that fails to pass through the nuclear pore (Fig. 3B).
Thus the C-terminal fusion, mGAT1–GFP, was the appropri-
ate candidate for further study. We constructed a lentivirus
expressing mGAT1–GFP and infected MDCK cells in culture.
The mGAT1–GFP construct was directed to the apical mem-
brane, as found previously for WT GAT1 expressed in MDCK
cells (Fig. 3G,H) (Ahn et al., 1996). We also infected hippocam-
pal neurons in primary culture and verified that the lentivirus-
encoded mGAT1 construct was directed to the plasma membrane
(Fig. 3I). These data showed that the mGAT1–GFP fusion pro-
tein fulfilled all of our qualitative and quantitative requirements,
at least in heterologous expression systems. mGAT1–GFP func-
tions like mGAT1 and is sorted like mGAT1.
mGAT1-GFP knock-in mouse: general pattern
of fluorescence
A knock-in mouse strain carrying the mGAT1–GFP fusion was
created by homologous recombination to replace the final coding
exon of mGAT1 (Fig. 1). There are only two differences between
genome of the mGAT1–GFP strain and the WT genome: the
coding region of mGAT1 has been extended at the C terminus by
the GFP37 sequence, and the adjacent exon retains a single 37 bp
loxP site (a vestige of the selection procedure for the embryonic
stem cells). Thus the encoded mGAT1–GFP gene matches the
cDNA construct that we chose in the experiments of Figure 3.
Homozygotes and heterozygotes from the mGAT1–GFP line
display normal weight, development, and life span, and, on the
basis of anecdotal observations, normal behavior.
Figure 4A presents a fluorescence image giving an overview of
the brain of an adult mGAT1–GFP knock-in mouse. The pattern
of fluorescence strongly resembles previous immunohistochemi-
cal findings: GAT1 is expressed in axons, in synapses, and in
astrocytes in many brain regions (Radian et al., 1990; Ikegaki et
al., 1994; Minelli et al., 1995; De Biasi et al., 1998; Yan and Ribak,
1998a,b; Wang and Ong, 1999; Ng and Ong, 2001). Wild-type
littermates showed no detectable background fluorescence (Figs.
5C, 6C). Figure 4B presents a quantitation of the fluorescence at
the cellular level in individual nuclei, normalized to the pinceaux
in cerebellum, which give the highest signal (Fig. 4D). The
absolute fluorescent intensities differed among animals by  7%
(SEM, n 	 3). In the glomeruli of the olfactory bulb, the superior
colliculus, the substantia nigra, and the magnocellular nucleus of
lateral hypothalamus, fluorescence was nearly as high (80–100%).
The molecular layer of the cerebellum displayed 60% expres-
sion, whereas the hippocampus, cortex, granule layer of the cer-
ebellum, and pons displayed 40–50% expression. The lowest level
of expression, 20–30%, is observed in cerebellar white matter,
thalamus, and striatum (Fig. 4B).
More detailed images show that mGAT1–GFP is expressed
primarily on axons and presynaptic boutons of GABAergic in-
hibitory neurons throughout the brain, again as revealed in pre-
vious studies. Figure 4, C and D, compares a previously published
immunocytochemical image of cerebellar cortex (Radian et al.,
1990) (shown as the negative, for better comparison with the
fluorescence) with a fluorescent image from an mGAT1–GFP
knock-in mouse. mGAT1 fluorescence occurs in a reticular pat-
tern in the molecular layer and in the pinceaux (named for their
resemblance to the paintbrushes of the French Impressionists),
which are processes of basket and stellate cells that surround the
initial segment of the Purkinje cell axon (Fig. 5D) (Palay and
Chan-Palay, 1974; Morara et al., 1996; Ribak et al., 1996). The
pinceaux were a focus of our quantitative studies (see below).
In other cerebellar cell types, mGAT1–GFP shows more dif-
fuse fluorescence. For instance, in some sections of the molecular
layer, we observed diffuse stripes of fluorescence (Fig. 5B,F);
these structures are probably the Bergmann glia (Rattray and
Priestley, 1993; Barakat and Bordey, 2002). In the glomeruli of
the granule cell layer, where GAT1 is expressed in the axons and
boutons of Golgi cells (Radian et al., 1990; Yan and Ribak,
1998a,b), fluorescence is also slightly diffuse, and no clearly
fluorescent axons or boutons were observed (Figs. 4D, 5B). Also,
in younger mice (for instance, at P9) (Fig. 5A), low levels of
diffuse, presumably intracellular expression were observed in
many cell types (Rosina et al., 1999).
In forebrain (including hippocampus), GAT1 is thought to be
expressed in GABAergic interneurons, including chandelier, bas-
ket, and dendritic inhibitory cells (Freund and Buzsaki, 1996) and
is particularly prominent on the cartridges formed by chandelier
cells on pyramidal neurons (Woo et al., 1998). Figure 4, E and F,
shows mGAT1 expression in the cartridges.
Figure 6 shows details of fluorescence in hippocampus. Figure
6, A and B, compares GAT1 localization during development.
The P9 knock-in mouse shows both synaptic and somatic expres-
sion, which agrees with other studies on young mice (Fig. 6A)
(Yan et al., 1997; Yan and Ribak, 1998a). mGAT1–GFP in P29
and older mice is no longer expressed in interneuron somata but
is expressed in axons and synapses throughout the hippocampus
and is especially high in the pyramidal cell layer (Fig. 6B); this
developmental pattern is similar to that in cerebellum (Fig.
5A,B). At higher magnification, images of stratum oriens (Fig.
6D) and stratum pyramidale (Fig. 6E) reveal axons and boutons
originating from chandelier and basket cells (Freund and
Buzsaki, 1996). In the excitatory cell layers in the CA regions and
in dentate gyrus, high levels of fluorescence but no clear synaptic
structures were observed. This is probably caused by the high
level of astroglial expression, which reduced our resolution at
individual synapses (Ribak et al., 1996) (Fig. 6E). Observations
on hippocampal cultures provide additional evidence for glial
GAT1 expression (see Fig. 10E). Slices from WT mice display
little or no fluorescence, even at higher incident light intensity
(Fig. 6C).
Counting mGAT1 molecules in cerebellum
The data presented thus far indicate that mGAT1–GFP fluores-
cence occurs as expected from previous studies, with regard to the
overall pattern of expression, the cellular localization, and the
time course of expression. We therefore proceeded to count
mGAT1–GFP molecules, with localization at the resolution of
confocal microscopy. These counts were based on two sets of
standards. The first standard was a set of transparent beads with
calibrated surface densities of GFP. The beads themselves were
calibrated on the basis of both single-molecule fluorescence mea-
surements and mass analyses of the GFP preparations used to
generate the beads (Chiu et al., 2001). The second standard was
a set of polyacrylamide gels with calibrated volume densities of
GFP, prepared from the same GFP preparations (see Materials
and Methods). For the present measurements, we developed
stereological procedures to quantify GFP fluorescence in
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micrometer-scale structures imaged in a series of confocal stacked
sections from brain tissue. These methods accounted for the
resolution of the microscope in the x-y plane and the z-axis (see
Fig. 8), for the scattering and loss of signal in tissue sections, and
for possible bleaching with prolonged exposure (see Materials
and Methods).
Our most detailed data are from cerebellar molecular layer
(ML), where the relatively large size of basket cell and stellate
cell boutons is well suited to our methods (Palay and Chan-Palay,
1974). The mGAT1–GFP fluorescent boutons have a diameter 
length of 1–1.5  2–3 m (Fig. 5E; also see Fig. 8A,B). We noted
two classes of structures with regard to fluorescent intensity and
have quantified these classes separately. Some 50–70% of bou-
tons and their connecting axons display the highest total
mGAT1–GFP fluorescence (Fig. 5E, arrows; also see Fig. 8A)
and will be described first. The average bouton volume is 1.84 
0.14 m3 and surface area is 6.73  0.43 m2. On the basis of
calibrations from polyacrylamide gels, the average total mGAT1–
GFP molecules in a bouton is 9000  640, representing a con-
centration of 4960  124 mGAT1–GFP per cubic micrometer. If
all mGAT1–GFP molecules are on the membrane, the surface
density is 1335  37 mGAT1–GFP per square micrometer (n 	
23). Quantifications based on the calibrated GFP-beads yield
surface densities 16% lower, at 1120  32 mGAT1–GFP per
square micrometer.
In boutons with higher mGAT1–GFP expression, we observed
higher mGAT1–GFP in subregions, 1.5–2-fold higher (see Fig.
8A). In sections simultaneously immunostained for GABAA re-
ceptors and imaged for GFP fluorescence, we have noted that
90% of the higher-expression boutons are associated with
GABAA receptors, suggesting that these are bona fide areas of
synaptic contact.
Figure 4. Overview of fluorescence in mGAT1–GFP mice. A, Montage forming a sagittal section 1.2 mm from the midline; homozygote. B, Relative
mGAT1–GFP fluorescence intensity in various regions. C, D, Cerebellar cortex; comparison of previously published immunohistochemistry (C) (Radian
et al., 1990), transformed to produce a negative image, with mGAT1–GFP expression ( D); heterozygote, single confocal image from a 35 m slice. E,
F, Frontal cortex, layer 5/6. The linear objects are chandelier cell cartridges (F, arrow) surrounding the initial segments of pyramidal cells. E, Single
confocal section from a heterozygote; F, projected stack (5 m thick) from confocal sections of a homozygote. OG, Glomeruli of olfactory bulb; AOL,
anterior olfactory nucleus; Fr, frontal cortex; Cpu, caudate putamen; Th, thalamus; SN, substantia nigra; MCLH, magnocellular nucleus of lateral
hypothalamus; CA1, field of Ammon’s horn in hippocampus; DG, dentate gyrus; SC, superior colliculus; GL, cerebellar granule layer; ML, cerebellar
molecule layer; Pi, pinceaux; Py, pyramidal cell; WM, cerebellar white matter; EPI, external plexiform layer in olfactory bulb; VP, ventral pallidum. Scale
bars: A, 1 mm; C–E, 50 m; F, 10 m.
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We now describe the 30–50% of boutons with lower fluores-
cence (Fig. 5E, arrowheads) (also typified by Fig. 8B). The bouton
volume is 1.35  0.15 m3, and surface area is 5.12  0.48 m2.
On the basis of calibrations from polyacrylamide gels, the average
total mGAT1–GFP molecules in a bouton is 5070  527, repre-
senting a concentration of 3850 126 GFP per cubic micrometer.
If all mGAT1–GFP molecules are on the membrane, the surface
density is 980  18 mGAT1–GFP per square micrometer (n 	
11). Quantifications based on the calibrated GFP-beads yield
surface densities 16% lower, at 820  40 mGAT1–GFP per
square micrometer. Thus the lower-intensity class of boutons
appear to express mGAT1–GFP at levels 64–75% of that of the
higher-intensity class.
The axons connecting the boutons have an apparent diameter
of 0.3 m (Fig. 5E,F), but this figure is near the limit of
resolution and must be considered approximate. We analyzed the
linear fluorescence density of axons that ran along the z-axis for
a distance 500 nm, or twice the theoretical z-axis resolution, so
that adjacent sections were averaged with little distortion from
edge effects. (We would prefer axons that run for 1 m, but the
tortuous course may vitiate such a search.) Axons in the higher-
intensity class showed fluorescence corresponding to 636  19
mGAT1–GFP molecules per micrometer (n 	 4). If one assumes
an actual diameter of 0.3 m, the membrane density of mGAT1–
GFP molecules is 677 per square micrometer, close to half that of
the boutons. Axons that connect lower-intensity boutons also
showed fluorescence at least 30% lower than the high-intensity
class.
Each cerebellar pinceau consists of dozens of intertwined basket
cell boutons and axons. Pinceaux vary in size and may sometimes
associate as linked pairs. We have treated pinceaux as solid objects.
The average volume and surface area of a pinceau are 1020  83
m3 and 470  12 m2 (n 	 8). The total of mGAT1–GFP
molecules in a pinceau is 7.8  106, and the average volume
density is 7700  443 GFP per cubic micrometer, or 55% higher
than the volume density in the high-intensity class of bouton.
We estimate that the density of mGAT1–GFP in Bergmann
glia is 1200–2000 GFP per cubic micrometer. Our observations
on GAT1 expression in these cells will be described in a separate
publication.
Figure 5. Details of mGAT1–GFP fluorescence in cerebellum, including individual boutons. A, In a P9 mGAT1–GFP mouse, mGAT1–GFP expresses
in somata of several cell types; however, no obvious axonal expression was observed. B, In a P29 mGAT1–GFP mouse, mGAT1–GFP is clearly expressed
in axons and boutons in the molecular layer (ML) and in pinceaux (arrows) surrounding the axonal hillock of Purkinje cells (P). The background
stripe-like structures in ML are probably Bergmann glia. C, The P29 WT shows low background fluorescence and no obvious structures. This image was
taken under 10-fold higher illumination photopower and has been further brightened digitally more than the other images. D, mGAT1–GFP expresses
in pinceaux (arrows) in the hillock of a Purkinje cell (P). E, mGAT1–GFP fluorescence in axons and boutons in ML. Boutons with higher (arrows) and
lower (arrowheads) levels of mGAT1–GFP are indicated. F, The diffuse stripe-like structures (arrows) represent the putative Bergmann glia expressing
mGAT1–GFP. This structure is most evident in horizontal sections, probably revealing the glial palisades of Altman (Altman and Bayer, 1997). ML,
Molecule layer; GL, granule cell layer; P, Purkinje. Scale bars: A–C, 50 m; D–F, 5 m. A, B, Single confocal slices from heterozygotes; D–F, projected
stacks (6, 4, and 4 m thick, respectively) from homozygotes.
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Counting mGAT1 molecules in cortex
and hippocampus
GAT1 is expressed on axons and boutons in cortex; boutons have
a diameter  length of 0.8  1.8 m. The average bouton
volume is 1.3 0.1 m3, and the average surface area is 3.3 0.2
m2. The volume and surface density of mGAT1–GFP expres-
sion are 3120  140 GFP per cubic micrometer and 1180  46
GFP per square micrometer (mean  SEM; n 	 8), respectively.
The volume and surface of the measured cortex cartridge are 188
m3 and 233 m2, respectively (n 	 1). The total GFP is 4.3 
105 per cartridge, and the average concentration is 2400 GFP
per cubic micrometer.
In hippocampus, the neuropil in the pyramidal cell layer showed
the highest levels of fluorescence, followed by stratum oriens (Fig.
6B). Presynaptic boutons of inhibitory neurons have only slightly
greater diameter than do axons and similar fluorescence levels;
therefore, in many cases the identification of a bouton is tentative.
We estimate that a bouton in stratum oriens has dimensions of
0.4–0.5  1.2 m, slightly larger than previous measurements
(i.e., 0.3  0.9 m) (Somogyi et al., 1983; Gulyas et al., 1993;
Halasy and Somogyi, 1993; Freund and Buzsaki, 1996). On the
basis of the polyacrylamide gel calibration, the average total num-
ber of mGAT1–GFP molecules in a bouton is 1200  40, and the
volume concentration is 6071 200 GFP per micrometer cubed. If
all mGAT1–GFP molecules are expressed on the surface, we
calculate a density of 800  24 GFP per micrometer squared. Our
measurements could be distorted by fluorescence point spread.
Direct measurements of surface fluorescence in boutons, based on
the GFP-bead calibrations, yield a surface mGAT1–GFP density
of 1218  59 GFP per square micrometer; we consider this the
more reliable measurement of surface density. Under the condi-
tions used for quantification of fluorescence in cortex and hip-
pocampus of mGAT1–GFP mice, there was little or no detectable
fluorescence in WT mice (data not shown).
Figure 6. Details of mGAT1–GFP fluorescence in CA1 region of hippocampus. A, In a heterozygous P9 mGAT1–GFP mouse, fluorescence is observed
both in somata of inhibitory interneurons (arrows) and at synapses near and in the pyramidal cell layer. B, In a 3 month postnatal homozygous mouse,
fluorescence is observed only in axons and synapses but not in somata. C, A P29 WT mouse shows low background fluorescence and no obvious
structures. This image was taken at 10-fold higher illumination photopower and has been further brightened digitally more than the other images. D,
High-magnification view of stratum oriens, showing fluorescent axons (arrows) and boutons. The dimmer background fluorescence could be caused by
expression in astrocytes. Brain tissues were prepared from homozygote, 60 d postnatal mouse. E, Neuropil (arrows) in pyramidal cell layers. The lack
of clear axon and bouton images could be attributable to mGAT1–GFP expression in both astrocytes and axons (Yan et al., 1997). Brain tissues were
prepared from homozygote, 60 d postnatal mouse. SO, Stratum oriens; SP, stratum pyramidale; SR, stratum radiatum. A, D, E, Projected stacks (5, 4,
and 4 m thick, respectively). Scale bars: B, 50 m; C, 40 m; A, D, E, 5 m.
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Surface/cytoplasmic partitioning of mGAT1–GFP in WT
and mGAT1–GFP mice
The mGAT1–GFP construct was selected because it expresses,
functions, and sorts like WT mGAT1 in heterologous expression
systems (Fig. 3). The comparisons between mGAT1–GFP fluo-
rescence and previous immunocytochemistry also show a good
agreement with regard to localization in the animals (Fig. 4).
Nonetheless, we found differences between the functional expres-
sion level of functional GAT1 in mGAT1–GFP knock-in animals
versus WT animals. We assayed crude synaptosome preparations
from knock-in and WT mice for [3H]GABA uptake (Fig. 7A). In
Scatchard analyses, the EC50 values for wild type, heterozygotes,
and homozygotes were 9.41, 11.95, and 11.47 M, respectively,
reaffirming that the mGAT1–GFP fusion construct functions like
the WT. However, the Vmax values of the three genotypes were
6.2, 5.2, and 2.2 (nanomoles per milligram of protein per 5 min),
respectively, consistent with the presence of approximately one-
third as many functional mGAT1–GFP molecules on the plasma
membrane as compared with WT (n 	 3 for each genotype) (Fig.
7A). In a total of six sets of synaptosome preparations each of the
three genotypes (three experiments with complete concentrations
series and three with a single [3H]GABA concentration), the
homozygote and heterozygote knock-in mice displayed 32  5%
and 76  7% (mean  SEM) of the WT activity, respectively.
Because of this unexpected threefold decrease in surface trans-
porter expression in mGAT1–GFP mice, we performed addi-
tional manipulations to ensure that fluorescence measurements
were made on mice with mGAT1–GFP molecules that were all
translocated to the cell surface (Corey et al., 1994; Beckman and
Quick, 1998; Bernstein and Quick, 1999; Whitworth and Quick,
2001a,b). Synaptosomes were incubated for 10 min with or-
thovanadate to inactivate tyrosine phosphatases, with bisindolyl-
maleimide II to inactivate PKC, and with 0.45 M sucrose to
suppress endocytosis, all at 4°C to further suppress endocytosis
(“translocation treatment”), followed by a 1 hr assay for
[3H]GABA uptake. Under these conditions, the untreated
mGAT1–GFP synaptosomes showed approximately one-third
the WT [ 3H]GABA uptake levels (Fig. 7B), in agreement with
the results for the assay at 37°C in Figure 7A. The translocation
treatment increased the [3H]GABA uptake by 60% in WT
synaptosomes (Fig. 7B), in agreement with previous data (Corey
et al., 1994; Beckman and Quick, 1998; Bernstein and Quick,
1999; Whitworth and Quick, 2001a,b). However, the translocation
treatment produced a much larger, 3.5-fold increase in the
mGAT1–GFP synaptosomes, to a level not significantly different
from the uptake activity of the orthovanadate-treated WT syn-
aptosomes (Fig. 7B). This suggested that the translocation treat-
ment placed all the transporters on the surface in a functional
state.
We performed surface biotinylation on cerebellar slices to
confirm and explain these manipulations as well as to estimate the
proportion of surface versus cytoplasmic transporters in WT mice
(Fig. 7C) (Beckman et al., 1999; Bernstein and Quick, 1999;
Horton and Quick, 2001). We found that the ratio of surface
mGAT1 to subsurface mGAT1 differed in WT and knock-in
mice. In WT mice, 63  8% of the mGAT1 was on the surface
membrane, but in mGAT1–GFP knock-in mice, only 24  11%
of the mGAT1 was on the surface. The translocation treatment
placed 90% of the GAT1 on the surface in both mGAT1–GFP
mice and WT mice (Fig. 7D) (this nearly complete pulldown also
provides assurance that the data from other manipulations can be
analyzed quantitatively to provide a surface/cytoplasmic ratio).
These data are consistent with the lower level of [3H]GABA
uptake in the mGAT1–GFP mice and with the increase produced
by the translocation treatment (Fig. 7A,B). Similar data were
Figure 7. GABA uptake and biotinyla-
tion assays for mGAT1–GFP partitioning.
A, Scatchard plot of [ 3H]GABA uptake
for all three mGAT1–GFP genotypes
(mean  SEM; n 	 3). Inset shows image
of green fluorescent synaptosomes. B, Ma-
nipulation of membrane/cytoplasmic par-
titioning, assayed by [ 3H]GABA uptake.
Data show NO-711-sensitive [ 3H]GABA
uptake, measured over a time course of 1
hr at 4°C. Synaptosomes were preincu-
bated for 10 min with control solution or
subjected to “translocation treatment”
with orthovanadate (50 M), bisindolyl-
maleimide II (100 nM) to inactivate PKC,
and 0.45 M sucrose, all at 4°C. C, Manip-
ulation of membrane/cytoplasmic parti-
tioning, assayed by surface biotinylation of
cerebellar slices. Lanes 1–4, Tissue from
mGAT1–GFP mice, probed with anti-
GFP antibody. Lanes 5–8, Tissue from
WT mice, probed with anti-GAT1 anti-
body. Lanes 1, 2, 5, and 6 were also probed
with anti-actin antibody. D, Quantitation
of immunostaining for mGAT1–GFP and
mGAT1 in lanes 1–8. y-axis shows per-
centage of total staining (intracellular 
extracellular) in the pair of lanes denoted
by similar patterns. Lane pairs 1  3, 2 
4, 5  7, and 6  8 add up to 100%. Data
are mean  SEM from three experiments
like that of C. E, Fluorescence intensity in
single boutons, untreated or subjected to
translocation treatment.
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obtained in surface biotinylation experiments on hippocampal
slices (data not shown).
We then performed additional fluorescence imaging experi-
ments on boutons in cerebellar slices, the structures that we
consider the most amenable to quantitative data. There was no
significant difference (3%) between the average mGAT1 fluo-
rescence of individual untreated boutons (n 	 35 boutons) and
those that were subjected to the translocation treatment (n 	 33
boutons) (Fig. 7E). These data show that the parameters of Table
1 may be interpreted as the maximal GAT1 density that can be
translocated to the surface membrane.
Many images of synaptic boutons (Figs. 5E, 8) show slightly
elevated fluorescence intensity in the intracellular compartment.
We asked whether this apparently intracellular fluorescence cor-
responds to the nonbiotinylated mGAT1. We compared the spa-
tial profile of fluorescence of the mGAT1–GFP on boutons from
the cerebellar molecular layer (Fig. 8A,B) with His6–GFP on the
surface of latex beads 1.5 m in diameter (Fig. 8C). The beads
also appeared to have a “tail” of internal fluorescence similar to
that of the boutons, and this tail did not change after translocation
treatment (Fig. 8D). We have not systematically explored the
cause of this fluorescence spread, but both the boutons and the
beads have elevated refractive indices relative to the external
solution, and this refractive index difference may distort the
optical signals slightly. Regardless of the source of this optical
effect, we conclude that our optical measurements do not resolve
a component of mGAT1–GFP fluorescence away from the sur-
face membrane. The data suggest that the cytoplasmic fraction of
cellular mGAT1 remains within a few hundred nanometers of the
surface membrane and cannot be distinguished from the fluores-
cence of surface-membrane mGAT1.
mGAT1–GFP mice display normal
GABAergic transmission
We measured spontaneous IPSCs in whole-cell patch-clamp ex-
periments on CA1 hippocampal pyramidal cells in slices from the
brains of WT and mGAT1–GFP mice (Fig. 9A). There were only
minor changes in average frequency, amplitude, and waveform of
these events between WT and mGAT1–GFP mice. We also
tested the effects of blocking GAT1 with NO-711 and found few
differences between the effects on WT and mGAT1 mice.
In previous experiments on CA1 hippocampal pyramidal cells,
pharmacological inhibition of GAT1 also produced tonic GABAA
currents, corresponding to a steady GABA concentration esti-
mated at 1 M (Frahm et al., 2001; Overstreet and Westbrook,
2001) (Tang et al., 2001). We therefore compared measurements
of tonic current in cells from WT and mGAT1–GFP mice (Fig.
9B). Perfusion of the GABAA antagonist SR-95531 (100 M)
Figure 8. Single-bouton images and point-spread function (A, B). Pro-
jections are of confocal stacks in cerebellar ML, 1–1.5 m thick. Scale bar,
1 m. A, Boutons with higher total mGAT1–GFP expression show sub-
regions of higher fluorescence. B, Boutons with lower fluorescence levels
show more evenly distributed fluorescence. C, Single confocal image of an
individual latex bead coated with His6–GFP. Scale bar, 1 m. D, Profiles
of GFP fluorescence in single confocal images of the beads (black),
boutons from slices subjected to translocation treatment (red), and bou-
tons from untreated slices (blue). Mean  SEM; n 	 16 each.




area (m2) Total mGAT1–GFP
mGAT1–GFP density
Volume
(/m3) Surface (/m2) Linear (/m)
Boutons, cerebellum 1.8 0.1 6.7  0.4 9000  640 4960  124 1340  95
Pinceaux, cerebellum 1020 470 (7.8  0.45)  106 7700  443
Axons, cerebellum High: 677  20 High: 636 19
Boutons, cortex 1.3  0.1 3.3  0.2 3300  326 2600  140 1000  100
Cartridge, cortex 188 233 3.6  105 2000
Boutons, hippocampus 0.2 1.5 1200  40 6070  200 800  24
The cells in bold present the parameters that we consider most reliable.
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produced a complete silencing of spontaneous IPSCs as well as a
positive shift in the holding current, corresponding to the tonic
GABAA current (Fig. 9B). mGAT1–GFP and WT cells displayed
equal tonic currents, showing that GABAA receptors in mGAT1–
GFP mice, like receptors in WT mice, can detect elevated extra-
cellular GABA concentrations (Fig. 9B); these receptors are
presumably located extrasynaptically. In the absence of NO-711,
SR-95531 perfusion again silenced spontaneous IPSCs but pro-
duced much smaller (and equal) tonic current in either WT or
mGAT1–GFP cells (Fig. 9B). This shows that mGAT1–GFP is
able to prevent spillover of GABA onto receptors responsible for
the tonic current.
Cultured neurons make inhibitory synapses if and only
if they are fluorescent
Figure 10, A and B, shows micrographs of dissociated cultures
from mGAT1–GFP knock-in embryo hippocampus, cultured at
E16 and studied after 16 d in culture. Of the cultured neurons,
10–20% are fluorescent. mGAT1–GFP is expressed throughout
these cells, similar to our observations of early postnatal mice
(Fig. 10A,B). Although the fluorescence in mice became re-
stricted to axons and synapses after the third postnatal week
(Figs. 5A,B, 6A,B), the pattern of whole-cell fluorescence per-
sisted after 29 d in culture, suggesting that the details of
localization differ between cells in dissociated culture and in vivo.
A previous report shows that GAT1 immunocytochemistry per-
sists in the soma and dendrites of cultured rat hippocampal
neurons, ruling out major effects of the GFP moiety in this case
(Pietrini et al., 1994).
The major goal of the culture experiments was to determine
whether the set of fluorescent neurons is identical to the set of
GABAergic interneurons. Neurons of homozygous or heterozy-
gous mGAT1–GFP mice were cultured for 8–14 d and then
screened, in paired whole-cell patch-clamp recordings, for the
presence of synaptic connections (Fig. 10C,D). Thirty-nine fluo-
rescent cells were stimulated in this series of experiments. Thirty-
four of the fluorescent neurons induced postsynaptic currents in
the second, nonfluorescent neuron of a cell pair (Fig. 10C). In all
cases the reversal potential of this current, when corrected for the
liquid junction potential, was approximately80 mV, close to the
equilibrium potential for Cl under our experimental conditions.
These putative IPSCs were blocked both by picrotoxin and by
bicuculline (40 M; each of four and six tested synapses, respec-
tively). Furthermore, in one tested pair of fluorescent neurons,
there were reciprocal inhibitory synaptic currents. These data
indicate that all tested fluorescent cells were GABAergic inhibi-
tory neurons.
In 30 tested pairs of nonfluorescent cells, there were 36 syn-
apses. In all cases the reversal potential of the postsynaptic
current induced by stimulation of nonfluorescent cells was more
positive than 20 mV. This current was also characterized by
faster decay when compared with the postsynaptic current in-
duced by stimulation of fluorescent cells (Fig. 10D shows an
example). Both reversal potential and more rapid decay of these
postsynaptic currents indicate the excitatory nature of nonfluo-
rescent cells. In all four tested cases, these putative excitatory
currents were blocked by CNQX (10 M), confirming their glu-
tamatergic nature. In 39 cases, we stimulated a nonfluorescent
neuron and recorded from a fluorescent neuron; there were 26
and 0 cases of EPSCs and IPSCs, respectively.
Thus the set of fluorescent neurons in hippocampal cultures
equals the set of GABAergic interneurons. Fluorescent neurons
formed boutons on nearby nonfluorescent neurons (Fig. 10E) as
well as on themselves, and these boutons are probably some of the
inhibitory synapses.
We make an additional, more technical point. The fluorescent
interneurons were detected readily in a standard inverted micro-
Figure 9. Electrophysiology of GABAer-
gic transmission to CA1 pyramidal neu-
rons in hippocampal slices from WT and
mGAT1– GFP mice. A, Spontaneous
GABAA-mediated IPSCs in Cl
-loaded
CA1 pyramidal cells (holding potential,
70 mV). Averages of 50 IPSCs from WT
and mGAT–GFP slices are shown. Right-
hand panel shows mean  SEM of several
parameters. B, Tonic GABAA receptor-
mediated currents recorded in C l-
loaded CA1 pyramidal cells (holding po-
tential, 70 mV). In the presence of NO-
711 (10 M), application of the GABAA
receptor antagonist SR-95531 (100 M)
blocked the spontaneous I PSC s and
caused an outward shift in the baseline by
30–40 pA. This change represents the
tonic GABAA receptor-mediated current
and was observed in cells from both WT
and mGAT1 mice. The right-hand panel
shows mean SEM of the tonic current in
WT and mGFP slices, in the presence and
absence of NO-711.
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scope equipped with an Hg lamp, a GFP fluorescence cube, and
a 20 (NA 0.4) objective. Even the heterozygotes produced
unambiguous fluorescent neurons, leading us to expect that in-
hibitory neurons would be detectable if the homozygous mGAT1–
GFP mice are crossed with other mouse strains. In data not
shown, we have confirmed that inhibitory neurons were detected
in cultured hippocampus when the mGAT1–GFP line was
crossed to lines carrying point-mutant nicotinic receptors (La-
barca et al., 2001) or point-mutant serotonin 5-HT3 receptors.
DISCUSSION
This paper describes, to our knowledge, the first knock-in mouse
strain that carries a GFP-tagged protein for the purpose of count-
ing and localizing molecules of that protein. We conclude that
GAT1 molecules are present at surface densities of 800–1300 per
square micrometer in presynaptic boutons, that a single basket cell
bouton in cerebellum contains 9000 mGAT1 molecules, and that a
pinceau contains 7.8  106 molecules. Additional biotinylation
experiments show that 61–63% of these molecules are on the
surface membrane; the remainder are within a few hundred nano-
meters in the cytoplasm. These impressively high numbers agree
with previous guesses (see introductory remarks).
The study uses the absolute calibrations provided by previously
developed transparent agarose beads with known surface densi-
ties of GFP (Chiu et al., 2001). In the present study, the bead
method was extended to gels containing known densities of GFP
(Hack et al., 2000).
The knock-in GFP method, accompanied by biochemical anal-
ysis of surface/cytoplasmic partitioning, complements several
other techniques appropriate for quantifying synaptic proteins.
Quantitative immunogold electron microscopy has provided quite
useful estimates for GABAA and AMPA receptor density
(Nusser et al., 1997, 1998a,b), at the resolution of the electron
microscope, but involves uncertainties arising from the efficiency
Figure 10. Electrophysiological measurements show that inhibitory interneurons fluoresce in hippocampal dissociated culture. A, B, Cultured
hippocampal neurons were imaged with 10 (A) and 20 ( B) objectives. The images show the fluorescent neurons under epifluorescence (lef t) and all
neurons under transmitted light (right). The merged images are shown in the center panels. There are 16–18 fluorescent neurons in A and 5 (of which
the 2 most obvious are marked with arrows) in B. Scale bars: A, 100 m; B, 50 m. C, D, Exemplar waveforms of voltage–clamp currents recorded from
nonfluorescent postsynaptic cells studied at various holding potentials. C, Records during stimulation of a fluorescent presynaptic cell. D, Another cell;
records during stimulation of a nonfluorescent presynaptic cell. E, The axon of a dissociated hippocampal interneuron forms synaptic boutons on nearby
excitatory neurons. Scale bar, 20 m. Left panel, Fluorescence only; arrows point to boutons that make contact on a nonfluorescent soma. Right panel,
Fluorescence overlaid on Nomarski image of the culture. In the right-hand panel, the pointer identifies a glial cell expressing GAT1 (arrowhead).
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of antibody binding and section thickness. A volume measure-
ment method yields the average density of a specific protein on
the plasma membrane (Lehre and Danbolt, 1998) but cannot give
local densities of a variably distributed protein (for instance, at
synapses). Autoradiography with a specific ligand (Anglister et
al., 1994) requires a specific, irreversibly bound ligand; these are
unavailable for most channels and receptors, including GAT1,
and in any case cannot be used on living tissues.
The mGAT1–GFP mouse displays apparently normal life span,
reproductive behavior, and weight, and mostly normal tonic and
phasic inhibitory synaptic transmission (Fig. 9), despite a three-
fold decrease in surface GAT1 function. These observations
agree generally with clinical observations that the anti-epileptic
GAT1 inhibitors, such as tiagabine, are well tolerated at doses
that produce only partial mGAT1 blockade. The present project
has also unexpectedly generated a genuine mGAT1 knock-out,
the homozygous intron 14-Neo-mGAT1 mice (Jensen et al., 2001)
(Fig. 1). We will report elsewhere on extensive electrophysiolog-
ical and behavioral differences between homozygous intron 14-
Neo-mGAT1 and WT mice. The intron 14-Neo-mGAT1 hetero-
zygote, however, which has half-normal GAT1 function, displays
few if any deficits. This is consistent with the normal phenotype
of the mGAT1–GFP mice despite their threefold lower GABA
uptake.
Sorting and membrane/cytoplasmic partitioning
of mGAT1–GFP
We performed preliminary experiments with heterologous ex-
pression to define the proper mGAT1–GFP fusion (Fig. 3). On
the basis of GABA uptake assays in HEK cells, the 12-residue
spacer followed by GFP preserved the EC50 for GABA and the
expression level (Fig. 3). On the basis of localization in MDCK
cells, the additional sequences also preserved cellular localization
(Fig. 3). However, synaptosomes from mGAT1–GFP mice dis-
play only approximately one-third as much surface functional
GAT1 as WT mice, and surface biotinylation shows that most of
the mGAT1–GFP remains intracellular (Fig. 7). GAT1 is dynam-
ically regulated in neurons, moving from the cytoplasmic vesicles
to the surface membrane on a time scale of minutes in response
to regulation by several pathways, including phosphorylation and
interactions with syntaxin (Corey et al., 1994; Beckman and
Quick, 1998; Bernstein and Quick, 1999; Whitworth and Quick,
2001a,b). We used pharmacological manipulations of this traffick-
ing to localize all of the GAT1 on the surface membrane (Fig. 7),
and then repeated the measurements under these same condi-
tions, to remove cytoplasmic/membrane partitioning as a possible
source of ambiguity in the total (cytoplasmic plus membrane)
measured densities.
The source of the abnormal cytoplasmic/membrane partition-
ing in mGAT1–GFP mice is suggested by a recent study showing
that the final three residues of GAT1, AYI, interact with pals1, an
endogenous PDZ domain protein (McHugh et al., 2001). In HEK
cells, which do not express pals1, WT GAT1 shows the same
functional expression level as GAT1 minus the terminal AYI
sequence or as GAT1 minus the terminal AYI sequence with
coexpression of pals1. However, HEK cells coexpressing pals1
and WT GAT1 display three times greater GABA transport. We
do not yet know whether the lack of a PDZ interaction decreases
the rate of exocytosis or increases that of endocytosis. Nonethe-
less, these data explain how the intact mouse displays threefold
lower GAT1 activity, despite the functional data of Figure 3.
Thus, the present knock-in mouse strain has one important dif-
ference from WT mice, but importantly, the present data also
suggest that a PDZ interaction enhances surface localization of
GAT1, extending previous conclusions based on a heterologous
expression system.
Any GAT1–GFP knock-in mouse would also be subject to
dynamic regulation of membrane/cytoplasmic partitioning, al-
though the equilibrium is shifted toward membrane expression in
the presence of a proper PDZ interaction (Corey et al., 1994;
Beckman and Quick, 1998; Bernstein and Quick, 1999; Whit-
worth and Quick, 2001a,b). The data of Figure 7 show that an
average of 39% (based on the [3H]GABA uptake data) or 37%
(based on the biotinylation data) of GAT1 is intracellular in WT
mice. Because untreated synapses and translocation treatment
synapses showed indistinguishable densities and fluorescence
profiles (Fig. 8), we suggest that the intracellular mGAT1–GFP
remains near the surface membrane (within the resolution of the
confocal microscope). The entire pool of 1000–1300 GAT1 mol-
ecules per square micrometer (Table 1) is potentially available for
surface function. This value may vary locally, leading to uncer-
tainty that exceeds the systematic factors discussed in the next
section.
Other sources of variation and systematic error
Several additional factors introduce variation into our range of
mGAT1 counts. In cortex and hippocampus, differential expres-
sion of several genes defines subsets of inhibitory interneurons
(Seress et al., 1993; Acsady et al., 1996; Gulyas et al., 1990, 1996;
Hajos et al., 1996, 2000; Kiss et al., 1997; Blasco-Ibanez et al.,
1998; Katona et al., 1999; Emri et al., 2001). In hippocampus, we
usually found that stratum radiatum had lower fluorescence than
stratum oriens or stratum lacunosum moleculare. Although the
culture experiments show that all GABAergic neurons express
mGAT1 robustly, this difference warrants systematic study in view
of observations in rats that, in stratum radiatum, evoked IPSCs
are prolonged to a greater extent by tiagabine (Engel et al., 1998).
The accuracy of volume and surface measurements on boutons
depends on their size and the point-spread function. For the
larger boutons, such as those in ML of cerebellum, we have
relatively accurate measurements that define the relations among
integrated fluorescence, volume density, and surface density. For
smaller boutons, such as those in hippocampus, the resolution in
the x-y plane and z-axis are limiting factors. Although integrated
numbers of mGAT1–GFP molecules have good accuracy, the
uncertainties about membrane density in hippocampus may ap-
proach a factor of 2.
Several other factors are primarily related to instrumentation
and might introduce systematic errors. Previous measurements on
the GFP beads indicate that we understand their surface densities
to within 20% (Chiu et al., 2001). The bead-based and polyacryl-
amide gel-based measurements involve substantially different
analyses and independent calibration series, except that the poly-
acrylamide gel analysis assumes that 100% of the His6–GFP
molecules are active, a point proven only for the His6–GFP
molecules tethered to the beads (Chiu et al., 2001). We are
encouraged that these two measurement series agree within
20% when both are applied to determine the membrane density
of mGAT1–GFP molecules at cerebellar boutons, which have
good geometric properties for both analyses. Nevertheless, possi-
ble sources of systematic errors include mismatch of refractive
index and other sources of light scattering. We measured the
decrement in fluorescence intensity within a tissue slice and
concluded that, within the first 4 m, the fluorescent intensity
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dropped 10% (see Materials and Methods). Stability of GFP
during sample preparation has been monitored and appears to
add little error (see Materials and Methods). Background sub-
traction is straightforward. Bleaching corrections are straightfor-
ward based on laser power, which we monitored; fluctuations were
on the order of 5%. We consider it likely that systematic errors
of the type discussed in this paragraph amount to 30%. The
measurements are now limited principally by instrumentation
(20%) and perhaps by a series of systematic errors that might
total 30%. The usual methods for propagating errors suggest that
these fractions should be added in quadrature, for a total error
of 36%.
GABAergic interneurons in culture
The experiments on hippocampal cultures emphasize the preci-
sion of the knock-in construct by showing that virtually all
GABAergic neurons, and only GABAergic neurons, show robust
mGAT1–GFP fluorescence. GAT1 thus takes its place as one of
the genes common to all inhibitory interneurons.
Some interneurons are readily identifiable in hippocampal cul-
ture because they are round and unusually large. However, phys-
iological researchers routinely find that many cultured inhibitory
neurons resemble pyramidal cells. The mGAT1–GFP mouse
provides an unambiguous method to choose living GABAergic
neurons for various studies.
Implications of the measurements
The present number for the average density of GAT1 in a
presynaptic bouton is 800–1300 per square micrometer. Because
of dynamic partitioning between cytoplasm and surface mem-
brane, 61–63% of this number (average value) is on the surface
membrane of WT mice in the absence of special treatments. We
also observe localized zones of 50–100% higher density, perhaps
corresponding to synapses. These densities roughly equal our
expectation when we began the project (see introductory re-
marks). This density is not limited by membrane packing, because
GAT1 can be expressed in Xenopus oocytes at densities exceeding
10,000 per square micrometer (Mager et al., 1993). Glutamate
transporters occur at densities three- to fivefold higher than
GAT1 in cerebellar molecular layer (Lehre and Danbolt, 1998),
yet these GAT1 densities are sufficient to shape the time course of
the evoked IPSC and to suppress tonic conductance at extrasyn-
aptic GABAA receptors.
Acetylcholinesterase is present in several-fold excess at nerve–
muscle synapses (Anglister et al., 1994). One cannot yet conclude,
simply because the mGAT1–GFP mice serendipitously display
normal synaptic transmission but approximately fourfold lower
overall GAT1 surface expression, that a similar excess applies to
GAT1, because the decrement could vary by cell type and by
region on the cell. Both the present knock-in mice expressing
fluorescent mGAT1 and the related mGAT1 knock-out strain
provide an appropriate source of preparations to approach such
questions systematically.
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